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INTRODUCTION:  Ewing  sarcoma/Primitive  neuroectodermal  tumor  of  the  kidney  (ES/PNET)  is a member
of Ewing’s  sarcoma  family,  occurring  in  young  adults  and  has  aggressive  clinical  behavior  and  poor  prog-
nosis.  However,  its discrimination  from  the renal  cell carcinoma  (RCC)  is  very  difﬁcult  preoperatively.
We  present  three  cases  of this  rare  disease  that were  managed  in  two academic  centers.
PRESENTATION  OF  CASES:  Herein  we report  three  cases  of  ES/PNET  of  the  kidney,  2  young  men  complain-
ing  of right  ﬂank  pain  and  gross  hematuria  and  one  young  woman  complaining  of left  subcostal  pain.  In
two  cases  computerized  tomography  (CT)  scan  revealed  huge  renal  masses  which  were  excised  by radical
nephrectomy.  Microscopic  examination  of  the  nephrectomy  specimen  showed  primitive  neuroectoder-
mal  tumor  features  which  conﬁrmed  by  immunohistochemistry  (IHC).
Two  of 3 patients  were  treated  with  adjuvant  chemotherapy  and  the third  patient  with neoadjuvant
chemotherapy.  They  were  symptom-free  until  now.
DISCUSSION:  The  clinical  course  and  prognosis  of ES/PNET  are  different  from  renal  cell carcinoma  (RCC)
and  deﬁnite  pathologic  diagnosis  is  necessary  for optimum  treatment.  For  deﬁnite  diagnosis,  in addition
to  cytogenetic  analysis;  other  techniques  may  be needed;  such  as  ﬂuorescent  in situ hybridization  (FISH),
reverse  transcriptase-polymerase  chain  reaction  (RT-PCR)  of the  t (11;  22) translocation  or the  EWS-FLI
and  related  gene  fusions  [1].
CONCLUSION:  Up  to our  knowledge  and  search  in  English  literature,  this  is  the  ﬁrst case  series  that  was
reported  from  a major  referral  center  from  our  country,  Iran.
© 2016  The  Author(s).  Published  by Elsevier  Ltd on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Case presentation
.1. First case
A 21-year-old man  was referred to our hospital in August 2010,
ith right ﬂank pain and weight loss. Abdominopelvic computer-
zed tomography (CT) scan showed a right renal mass. The patient
nderwent right radical nephrectomy with primary diagnosis of
CC.
Cut sections of nephrectomy sample showed variegated creamy
 brown soft to rubbery mass measuring 18 × 8 × 5 cm,  showing foci
f necrosis, which pushed pyelocalyceal system medially. Tumor
dhesion to renal capsule was identiﬁed. Ureter was  free from any
umor grossly.
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reativecommons.org/licenses/by-nc-nd/4.0/).Microscopic examination of H&E slides showed solid sheets of
rather monotonous population of small tumoral cells character-
ized by round nuclei; coarse chromatin pattern with indistinct cell
outlines which in some areas arranged as vague pseudo-rosette
fashion. Necrosis was  dominated.
Immunohistochemical studies (IHC) showed positive immune
reactions for CD99 (membranous staining in tumoral cells), NSE
(cytoplasmic staining in tumoral cells) and negative reactivity for
CD45, CK7, CK20, synaptophysin and chromogranin, consistent
with the diagnosis of ES/PNET (Fig. 1).
1.2. Second case
A 31-year-old man  was referred to our center in April 2013,
with the chief complaint of gross hematuria. There was  no history
of smoking and past medical or surgical problems in the patient.
Physical examination was unremarkable.
Renal ultrasonography showed hypoechoic mass in lower pole
of right kidney, measuring: 30 × 18 mm.  Intravenous pyelography
showed non secretion of involved right kidney. Abdominopelvic CT
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Microscopic examination and IHC study of tumoral cells (×400).
(A) H&E: Discohesive small round cells arranged as vague rosettes.
(B)  CD 99: Positive membranous staining in tumoral cells.
(C) NSE: Positive cytoplasmic staining in tumoral cells.
(D) CD 45: Negative in tumoral cells.
(E) CD 56: Negative in tumoral cells.
(F) CK 7: Positive cytoplasmic staining in surface urothelial cells and negative in tumoral cells.
G-  CK 20: Negative in surface urothelial cells and tumoral cells.
H-  Synaptophysin: Negative in tumoral cells.
I- Chromogranin: Negative in tumoral cells.
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wig. 2. Nephrectomy specimen after neoadjuvant chemotherapy. Only a necrotic are
xamination.can showed an exophytic mass with pressure effect over the pelvis
hat caused pelvic dilatation. Rigid ureterorenoscopy of right ureter
as done which was unremarkable. Then open right renal biopsynoted in lower pole which failed to prove any residue of tumoral cells in microscopicwas performed. Microscopic examination revealed fragments of
normal urothelial mucosa underlined by a neoplastic tissue com-
posed of diffuse growth pattern of tumoral cells, characterized
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Fig. 3. CT scan of the third case revealing a large inhomogenous left renal mass
occupying the left side of abdomen.CASE  REPORT
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y uniform hyperchromatic nuclei and scant cytoplasm, admixed
ith necrotic areas. The morphologic features were showed a“small
ound cell tumor” compatible with ES/PNET.
IHC studies showed negative immune reactions for CK7, CK20,
D56, chromogranin, synaptophysin, CD45, CD3 and CD 20 but NSE
nd CD99 were positive in tumoral cells. Real time PCR on parafﬁn
mbedded blocks proved the presence of t (11–22) (EWS-FL1 fusion
ranscript), which conﬁrmed the diagnosis of ES/PNET. The patient
nderwent 9 courses of neoadjuvant chemotherapy and then right
ided radical nephrectomy was performed by attending staff.
Sections of radical nephrectomy showed a yellow soft lesion
esembling necrosis in lower pole measuring 2 × 2 × 2 cm (Fig. 2).
rossly no tumoral lesion was identiﬁed. Microscopic examina-
ion of H&E stained slides showed foamy macrophages, admixed
ecrotic areas probably due to therapy related changes. No tumoral
esidue was found.
.3. Third case
The patient was a 34 years old female who was referred to our
enter with abdominal swelling associated with left lower chest
ain since one month before admission.
In physical examination a large abdominal mass ﬁlling the left
ide of abdomen was detected.
In abdominopelvic ultrasonography, a huge abdominal mass
as reported. In abdominopelvic contrast enhanced CT scan (Fig. 3)
 large left renal mass was conﬁrmed. Metastatic work up was neg-
tive. The patient underwent left radical nephrectomy with midline
aparotomy incision. Severe adhesions were present without gross
ymph nodes enlargement. The pathology diagnosis was  in favor
f ES/PNET of the kidney (Figs. 4 and 5). The patient underwent
djuvant chemotherapy.
. Discussions
Ewing sarcoma/Primary neuroectodermal tumor (ES/PNET) of
he kidney as a primary renal tumor is a rare entity; ﬁrstly described
n 1975 [1] . Fewer than 150 cases were reported in the literature till
ow [2] . It is a member of Ewing’s sarcoma family, with aggressive
linical behavior which usually occurs in young adults most often
etween 20 and 30 years. The male: female ratio is about 3:1 [3].
The major differential diagnosis of small-round cell tumors
f the kidney includes: malignant lymphoma, embryonal rhab-
omyosarcoma, renal neuroblastoma, Wilms  tumor, small cell
steosarcoma, and Ewing sarcoma (ES) or its variant with neural
ifferentiation, primary neuroectodermal tumor (PNET) [4].
ES/PNET of the kidney usually reaches huge size and is almost
lways more than 10 cm in maximum diameter [4–6].The largest
ase series including 146 patients with ES/PNET was  described in
001 by Parham et al. [6]. The age of patients ranging from 2 months
o 73 years (median: 20 years). Another large series reported by
ollner et al. [4]. They found 24 cases in German database from 1980
o 2009. The median age was 24.9 years (range 11–60 years). In
7.5%, patients presented with metastases. In 90% rearrangements
f t (11, 22) were found.
Clinical symptoms and para-clinical data are similar to renal cell
arcinoma; therefore deﬁnitive diagnosis needs pathologic con-
rmation with immunohistochemical (IHC) studies. IHC studies
howed more than 90% positivity for CD99, but CD99 is not spe-
iﬁc and cannot be used as an absolute biomarker for its diagnosis
7,8].Cytogenetic analyses can be helpful in the diagnosis of ES/PENT
howing Ewing sarcoma (EWS) gene and ETS translocation.The
ranslocation of t (11:22) (q24:q12) have been detected in more
han 90% of the ES/PNET of the kidney [5].ES/PNET of the kidney has more aggressive behavior than PNET
of other sites [6].
Macroscopically many of the cases are located in the
medullary/pelvic region of the kidney. Distant metastases occur in
about 20 to 50% of patients; most commonly to regional lymph
nodes. Metastases to the bone, bone marrow, lung, and liver are
not uncommon [3].
The 5-year survival of ES/PNET of the kidney is about 45–55%
[9,10].
Metastases to the regional nodes or distant metastases decrease
overall survival in comparison with localized ES/PENT of the kidney
[11] .
The main differential diagnosis is with blastema-predominant
Wilms  tumor.
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Fig. 4. Small round cells with high N/C ratio, rather round monotonous nuclei and scanty cytoplasm (×400).
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. Conclusions
Like other case reports of ES/PNET of the kidney our cases were
anifested by renal masses which treated by radical nephrectomy
n combination with chemotherapy. Microscopic features were in
avor of small round cell tumor and ﬁnal diagnosis was  conﬁrmed
y IHC staining. Up to our knowledge and search in English litera-
ure, only one case was previously reported from Iran [9].
It’s noteworthy that our work has been reported in line with the
CARE criteria of case reports [12].
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